{"schema_version":"secwatch.filing_event.v1","accession":"0001013762-23-003856","form_type":"8-K","ticker":"KTTA","cik":"0001841330","company_name":"Pasithea Therapeutics Corp.","filed_at":"2023-10-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:30.955899+00:00","generated_at":"2026-06-10T00:10:19.122902+00:00","sec_items":["5.08"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Pasithea Therapeutics sets 2023 annual meeting for Nov 29; shareholder proposal deadline Oct 23","bullets":["Annual meeting set for November 29, 2023; proxy materials to be delivered around October 23, 2023.","Rule 14a-8 shareholder proposals must be received by October 23, 2023, at company's Miami Beach office.","Bylaw director nominations and other proposals due by October 23, 2023.","Universal proxy rule notices for non-company nominees also due by October 23, 2023."],"urls":{"canonical":"https://secwatch.observer/filing/0001013762-23-003856","json":"https://secwatch.observer/filing/0001013762-23-003856.json","markdown":"https://secwatch.observer/filing/0001013762-23-003856.md","text":"https://secwatch.observer/filing/0001013762-23-003856.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1841330/000101376223003856/0001013762-23-003856-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1841330/000101376223003856/ea186699-8k_pasithea.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T00:10:19.122902+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}